2011 biotech of the year , page-6

Hey Sclurnge / Marker,

i did notice the thread was very quiet with 4 or 5 long term holders. Chairmans update caught my attention last week & pushed me to look further.

Very exciting with such large libraries of diverse peptides under their control & the high level of interest from some of the largest pharmas in the world.

All backed by a very favourable business model.

PYC does seem very unnoticed & unloved where it is but highly encouraging that the majority of the listed securities are held firmly in the Top 20. I have had a pretty good look over all the devlopments of the past 18 or so months & the update does look like they're very close to stepping into the high return phase.

I take it from the recent update Roche's next move & an entirley new partnership are are on the cards in the very near future.

FWIW - Roche partnership was signed 12 months from this Saturday if they like keeping things within a year.....